complement component 3 deficiency

2 results · Page 1 of 1

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
A Phase 2 Study to Evaluate the Safety, PD, PK, and Clinical Activity of ADX-097 in Participants With IgAN, LN or C3G	Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, IgA glomerulonephritis, Male Urogenital Diseases, Skin and Connective Tissue Diseases, Urogenital Diseases, autoimmune disease, complement component 3 deficiency, connective tissue disorder, glomerulonephritis, immune system disorder, kidney disorder, lupus nephritis, nephritis, systemic lupus erythematosus, urinary system disorder	Recruiting	Phase 2	2026-10-01		NCT06419205
Immune System in Diabetic Kidney Disease	Diabetes Complications, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, Nutritional and Metabolic Diseases, Urogenital Diseases, complement component 3 deficiency, diabetes mellitus, diabetic kidney disease, endocrine system disorder, glucose metabolism disease, kidney disorder, metabolic disease, urinary system disorder	Enrolling by invitation	Not stated	2026-02-23		NCT07292493

Clinical trials